Netease Down Over 17%, on Pace for Largest Percent Decrease Since November 2005 — Data Talk
Netease Inc Sponsored ADR (NTES) is currently at $86.60, down $17.81 or 17.05%
--Would be lowest close since June 1, 2023, when it closed at $85.78
--On pace for largest percent decrease since Nov. 8, 2005, when it fell 21.9%
--Currently down two of the past three days
--Down 23.68% month-to-date
--Up 19.24% year-to-date; on pace for best year since 2020, when it rose 56.16%
--Down 34.62% from its all-time closing high of $132.47 on Feb. 11, 2021
--Up 21.82% from 52 weeks ago (Dec. 23, 2022), when it closed at $71.09
--Down 26.9% from its 52-week closing high of $118.47 on Nov. 20, 2023
--Up 21.82% from its 52-week closing low of $71.09 on Dec. 23, 2022
--Traded as low as $81.30; lowest intraday level since May 25, 2023, when it hit $80.79
--Down 22.13% at today's intraday low; largest intraday percent decrease since June 18, 2009, when it fell as much as 28.08%
All data as of 11:05:06 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
December 22, 2023 11:28 ET (16:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations